US Patent Issued on Nov. 3 for "Devices for treatment of meibomian gland dysfunction with mobile connectivity and artificial intelligence" (California Inventor)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,784,889, issued on Nov. 3.

"Devices for treatment of meibomian gland dysfunction with mobile connectivity and artificial intelligence" was invented by Lillie A. Mosaddegh (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "In some examples, a method for providing personalized treatment recommendations for Meibomian Gland Dysfunction (MGD) includes collecting, at a user device comprising one or more processors, sensor data from one or more sensors on a MGD treatment device being used for treatment of a user; supplying, at the user device, the sensor data to a machine learning model trained on training sensor data and training user outcome data; ...